Accelerated infliximab infusions for inflammatory bowel disease improve effectiveness

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 3, Issue 5

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

457

HTML

3891

Figures (1-3)

161

Tables (1-3)

147

Sum=4656

Oct 6, 2012 (publication date) through Apr 19, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Pharmacology and Therapeutics

ISSN

2150-5349

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastrointest Pharmacol Ther. Oct 6, 2012; 3(5): 74-82
Published online Oct 6, 2012. doi: 10.4292/wjgpt.v3.i5.74

Full Size Figure Download Figure

Figure 2 Number of accelerated infusions given to each patient in the study.

Citation: McConnell J, Parvulescu-Codrea S, Behm B, Hill B, Dunkle E, Finke K, Snyder K, Tuskey A, Cox D, Woodward B. Accelerated infliximab infusions for inflammatory bowel disease improve effectiveness. World J Gastrointest Pharmacol Ther 2012; 3(5): 74-82
URL: https://www.wjgnet.com/2150-5349/full/v3/i5/74.htm
DOI: https://dx.doi.org/10.4292/wjgpt.v3.i5.74